Published in Hepatitis Weekly, October 12th, 2009
"In addition to limited efficacy, treatment is often poorly tolerated because of side effects that prevent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.